DocDollars

Arbor Pharmaceuticals, Inc.

GA · United States · Reporting entity ID 100000005507

Total reported 2019–2025
$5.07M
#702 of 2,960 reporting companies — 0% of all reported industry payments
$1.43M in general payments across 77,481 records, plus $3.64M in research funding across 535 records.

How it breaks down

General payments $1,434,911
Research funding $3,636,896

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Arbor Pharmaceuticals, Inc. reported $5.07M to US doctors and teaching hospitals from 2019 to 2025, ranking #702 of 2,960 reporting companies. 72% of that was research funding and 28% general payments such as consulting, speaking, food and travel. 77,481 general payment records and 535 research records were filed.

Common questions about Arbor Pharmaceuticals, Inc.

How much has Arbor Pharmaceuticals, Inc. paid US doctors?

Arbor Pharmaceuticals, Inc. reported $5,071,806 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,434,911 in general payments, $3,636,896 in research funding.

How does Arbor Pharmaceuticals, Inc. rank among drug and device companies?

It ranks #702 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Arbor Pharmaceuticals, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.